Author:
Bidwell Bradley N,Slaney Clare Y,Withana Nimali P,Forster Sam,Cao Yuan,Loi Sherene,Andrews Daniel,Mikeska Thomas,Mangan Niamh E,Samarajiwa Shamith A,de Weerd Nicole A,Gould Jodee,Argani Pedram,Möller Andreas,Smyth Mark J,Anderson Robin L,Hertzog Paul J,Parker Belinda S
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference66 articles.
1. American Cancer Society. Breast Cancer Facts & Figures 2011–2012. <
http://www.cancer.org/Research/CancerFactsFigures/BreastCancerFactsFigures/breast-cancer-facts-and-figures-2011-2012
> (2012).
2. Fehm, T. et al. Tumor cell dormancy: implications for the biology and treatment of breast cancer. APMIS 116, 742–753 (2008).
3. Eckhardt, B.L., Francis, P.A., Parker, B.S. & Anderson, R.L. Strategies for the discovery and development of therapies for metastatic breast cancer. Nat. Rev. Drug Discov. 11, 479–497 (2012).
4. Dunn, G.P., Bruce, A.T., Ikeda, H., Old, L.J. & Schreiber, R.D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991–998 (2002).
5. Dunn, G.P. et al. A critical function for type I interferons in cancer immunoediting. Nat. Immunol. 6, 722–729 (2005).
Cited by
400 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献